Bangkok Lab and Cosmetic PCL
SET:BLC
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.02
6.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BLC stock under the Base Case scenario is 3.76 THB. Compared to the current market price of 5.35 THB, Bangkok Lab and Cosmetic PCL is Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bangkok Lab and Cosmetic PCL
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BLC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Bangkok Lab and Cosmetic PCL
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bangkok Lab and Cosmetic PCL
Balance Sheet Decomposition
Bangkok Lab and Cosmetic PCL
Current Assets | 1.7B |
Cash & Short-Term Investments | 955.5m |
Receivables | 347.5m |
Other Current Assets | 401.1m |
Non-Current Assets | 508.2m |
PP&E | 425.7m |
Intangibles | 9.9m |
Other Non-Current Assets | 72.6m |
Current Liabilities | 376.2m |
Accounts Payable | 107.7m |
Short-Term Debt | 104.4m |
Other Current Liabilities | 164.1m |
Non-Current Liabilities | 220.8m |
Long-Term Debt | 69.9m |
Other Non-Current Liabilities | 150.9m |
Earnings Waterfall
Bangkok Lab and Cosmetic PCL
Revenue
|
1.4B
THB
|
Cost of Revenue
|
-985.4m
THB
|
Gross Profit
|
449m
THB
|
Operating Expenses
|
-241.4m
THB
|
Operating Income
|
207.6m
THB
|
Other Expenses
|
-51.3m
THB
|
Net Income
|
156.3m
THB
|
Free Cash Flow Analysis
Bangkok Lab and Cosmetic PCL
THB | |
Free Cash Flow | THB |
BLC Profitability Score
Profitability Due Diligence
Bangkok Lab and Cosmetic PCL's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Bangkok Lab and Cosmetic PCL's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
BLC Solvency Score
Solvency Due Diligence
Bangkok Lab and Cosmetic PCL's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Bangkok Lab and Cosmetic PCL's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BLC Price Targets Summary
Bangkok Lab and Cosmetic PCL
Dividends
Current shareholder yield for BLC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bangkok Lab & Cosmetic PCL engaes in the provision of pharmaceuticals and health products. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-06-21. The firm is engaged in the production of medicines and health products by selecting raw materials. The firm has produced more than 100 products. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, and Calza-750 TAB FC, among others. Its products are distributed through Bangkok Drug Co., Ltd., Beereach (Thailand) Co., Ltd., Pharmaline Company Limited, Pharma Alliance Company Ltd., and Bangkok Medica Co., Ltd.
Contact
IPO
Employees
Officers
The intrinsic value of one BLC stock under the Base Case scenario is 3.76 THB.
Compared to the current market price of 5.35 THB, Bangkok Lab and Cosmetic PCL is Overvalued by 30%.